Catalog No. |
Information |
CFN95794 |
Strychnistenolide 6-O-acetate
|
CFN95795 |
cis-N-Terrestriamide
|
CFN95796 |
MTCA(1-Methyl-1,2,3,4-tetrahydro-beta-carboline-3-carboxylic acid)
|
CFN95797 |
Mangostanin
|
CFN95798 |
Mangostenone F
|
CFN95799 |
Mangostenol peroxide
|
CFN95800 |
Graciliflorin F
|
CFN95801 |
Aesculitannin B
|
CFN95802 |
Garcinexanthone C
|
CFN95803 |
16-Acetoxylsugiol
|
CFN95804 |
Auranamide
|
CFN95805 |
Gerardianin B
|
CFN95806 |
O-Methylglycosolone
|
CFN95807 |
Sinomenine N-oxide
|
CFN95808 |
Acutumine
|
CFN95809 |
New compound 40
|
CFN91441 |
Isoviolanthin
|
CFN95810 |
Tellimagrandin I
|
CFN95811 |
6,12,15-Trihydroxy-5,8,11,13-abietetra-7-one
|
CFN95812 |
15-O-Methylgraciliflorin F
|
CFN95813 |
Epigerardianin B
|
CFN95814 |
3alpha-Hinokiol
|
CFN95815 |
Graciliflorin E
|
CFN95816 |
Wulfenioidin G
|
CFN94538 |
Butenolide
|
CFN94570 |
Jasmonic acid
|
CFN95817 |
Bracteanolide A
|
CFN91440 |
Bruceoside B
|
CFN91439 |
Acacetin-7-O-6''-malonylglucoside
|
CFN91438 |
2-Methoxy aurantio-obtusin beta-D-glucoside
|
CFN91437 |
Toralactone
|
CFN91436 |
Rubrofusarin
|
CFN91435 |
Gluco-obtusin
|
CFN91434 |
Cassiaside C2
|
CFN91433 |
3beta-Methoxy-2,3-dihydro-4,7-didehydrophysalin B
|
CFN91432 |
Aloinoside A
|
CFN91431 |
Feruloylputrescine hydrochloride
|
CFN91430 |
Bufobutanoic acid
|
CFN91429 |
Benedictine
|
CFN91428 |
Stigmasterol 3-O-acetate
|
CFN91427 |
Clausine G
|
CFN91426 |
Dihydropinosylvin dimethyl ether
|
CFN91425 |
2',4-Dihydroxy-3,4',6'-trimethoxychalcone
|
CFN94333 |
Sodium Saccharin
|
CFN94332 |
Aspartame
|
CFN91424 |
Desoxylimonin
Desoxylimonin shows anti-proliferative activities to breast cancer cells. Desoxylimonin derivatives shows better anticancer, analgesic and anti-inflammatory activity than the lead compound. |
CFN91423 |
Dihydrocubebin
Dihydrocubebin is potent and selective inhibitors against cytochrome P450 3A4 (CYP3A4). |
CFN91422 |
Dihydrobetulinic acid
|
CFN91421 |
Dihydrolapachenol
|
CFN91420 |
Naringin chalcone
|